Invention Grant
- Patent Title: Dual GLP-1/GIP receptor agonists
-
Application No.: US14569260Application Date: 2014-12-12
-
Publication No.: US09751926B2Publication Date: 2017-09-05
- Inventor: Dieter Kadereit , Katrin Lorenz , Andreas Evers , Torsten Haack , Michael Wagner , Bernd Henkel , Martin Lorenz , Siegfried Stengelin
- Applicant: Sanofi
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Lathrop & Gage LLP
- Agent James H. Velema, Esq.
- Priority: EP13306713 20131213
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K45/06 ; C07K14/605 ; C07K14/575
Abstract:
The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.
Public/Granted literature
- US20150166627A1 Dual GLP-1/GIP Receptor Agonists Public/Granted day:2015-06-18
Information query
IPC分类:
